Projects per year
Personal profile
Education
- 2011 Dphil Clinical Pharmacology Department, University of Oxford
- 2005 M.S., Department of Biochemistry and Molecular Cell Biology, Taipei Medical University
- 2003 B.S., School of Pharmacy, Taipei Medical University
Experience
- 2020- Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2020- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2019-2022 Director, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2017-2020 Associate Professor, Department of Clinical Pharmacy, Taipei Medical University
- 2017-2020 Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2014-2017 Assistant Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2013-2017 Assistant Professor, Department of Clinical Pharmacy, Taipei Medical University
Research Interests
- Molecular mechanisms of tumorigenesis and translational medicine
- Toxicology and development of nanomaterials as drug delivery platform
- Protein post-translational modifications in cancer regulation
Fingerprint
Dive into the research topics where Er-Chieh Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
篩選發炎抑制劑與老藥新用NF-κB途徑抑制劑於HMGA2致癌級聯與大腸癌之治療潛力及分子作用機轉探討(2/3)
Cho, E.-C. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
篩選發炎抑制劑作為HMGA2過表現型大腸 癌之抗癌藥物探討
Cho, E.-C. (PI)
7/1/24 → 2/28/25
Project: A - Government Institution › b - National Science and Technology Council
-
篩選發炎抑制劑與老藥新用NF-κB途徑抑制劑於HMGA2致癌級聯與大腸癌之治療潛力及分子作用機轉探討(1/3)
Cho, E.-C. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
(教學實踐) 探討運用混成學習模式提升醫藥生技之臨床應用課程之學習成效
Cho, E.-C. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › d - Ministry of Education
-
應用發炎反應抑制劑對於致癌基因 HMGA2大量表現大腸癌之合併治療研究及調控分子機轉探討
Cho, E.-C. (PI)
7/1/22 → 2/28/23
Project: A - Government Institution › b - National Science and Technology Council
-
Molecular characterizations of nanodiamond and related carbon-based nanomaterials in the human cell line and zebrafish models
Li, M., Chang, C., Yeh, T. Y., Lee, T. Y., Lee, K. C. & Cho, E. C., Feb 2025, In: Diamond and Related Materials. 152, 111946.Research output: Contribution to journal › Article › peer-review
-
Construction of dual Z-scheme Ag3VO4–BiVO4/InVO4 photocatalysts using vanadium source from spent catalysts for contaminated water treatment and bacterial inactivation
Lee, K. C., Hsu, S. C., Huang, J. H., Wang, K. S., Pang, W. K., Hu, C. W., Jiang, Y. J., Cho, E. C., Weng, H. C. & Liu, T. Y., Sept 2024, In: Chemosphere. 363, 142746.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Crystal structure-controlled synthesis of NiMoO4/NiO hierarchical microspheres for high-performance supercapacitors and photocatalysts
Lee, K. C., Huang, J. H., Wu, Y. J., Wang, K. S., Cho, E. C., Hsu, S. C. & Liu, T. Y., Sept 1 2024, In: Journal of Energy Storage. 97, 112639.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways
Lee, H. Y., Hsu, M. J., Chang, H. H., Chang, W. C., Huang, W. C. & Cho, E. C., Jul 15 2024, In: Bioorganic and Medicinal Chemistry. 109, 117792.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Fabrication of hyaluronic acid with graphene quantum dot as a dual drug delivery system for cancer therapy
Lin, J., Lin, J. H., Yeh, T. Y., Zheng, J. H., Cho, E. C. & Lee, K. C., Mar 2024, In: FlatChem. 44, 100607.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus)
Datasets
-
Ring size changes in the development of class I HDAC inhibitors
Lee, H.-Y. (Contributor), Cho, E.-C. (Contributor), Tang, D.-W. (Contributor) & Liu, C.-Y. (Contributor), figshare Academic Research System, Jan 1 2021
DOI: 10.6084/m9.figshare.14843703.v1, https://tandf.figshare.com/articles/journal_contribution/Ring_size_changes_in_the_development_of_class_I_HDAC_inhibitors/14843703/1
Dataset
-
Structure-based virtual screening and biological evaluation of novel small-molecule BTK inhibitors
Lin, T. E. (Creator), Sung, L.-C. (Creator), Chao, M.-W. (Creator), Li, M. (Creator), Zheng, J.-H. (Creator), Sung, T.-Y. (Creator), Hsieh, J.-H. (Creator), Yang, C.-R. (Creator), Lee, H.-Y. (Creator), Cho, E.-C. (Creator) & Hsu, K.-C. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17162118.v1, https://tandf.figshare.com/articles/journal_contribution/Structure-based_virtual_screening_and_biological_evaluation_of_novel_small-molecule_BTK_inhibitors/17162118/1
Dataset